Form 4: Merck Director Thomas Glocer Reports Transaction in Company Stock

Director Thomas Glocer reports a transaction involving Merck & Co., Inc. stock, including the acquisition of phantom stock units.

Summary

• Thomas Glocer, a director at Merck & Co., Inc., filed a Form 4 with the SEC.
• The filing reports a transaction that occurred on September 30, 2024.
• Glocer disposed of 5,100 shares of common stock.
• Glocer acquired 429.2885 units of phantom stock, which are to be settled in cash upon termination of service.
• The price of the derivative security was $113.56.
• Following the reported transaction, Glocer beneficially owns 97,074.9536 derivative securities.
• Holdings include shares acquired in dividend reinvestment transactions.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting a transaction by a company director. It doesn't inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates changes in Director Glocer's holdings of Merck stock and derivative securities.

Stakeholder Impact

• Shareholders may be interested in tracking insider transactions as an indicator of management's view of the company's prospects.

Key Dates